Y-K An - Dept Gastroenterol, Mater Hosp Brisbane

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 22 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Burden of disease for inflammatory bowel disease in Australasia: Crohn's Colitis Cure data insights program

J. Mcnamara,W. Wilson, J. Pipicella, T. Goodfellow, A. Kim, R. Gearry, A. Forbes,Y-K An, W. Ng, K. Lynch, I. Lawrence, M. Schultz,

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023): 164-164

引用0浏览0引用

Upadacitinib for rescue therapy in patients with acute severe ulcerative colitis: An Australian real-world experience

W. L. Tan, R. Gilmore, A. Huang, R. Fernandes,Y-K An, J. Begun

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023): 182-182

引用0浏览0引用

Patients from East Asia with acute severe ulcerative colitis have worse endoscopic severity but are more responsive to intravenous steroids than patients from Australasia: Preliminary results of the APAC-ASUC study in collaboration with the ANZIBDC and AOCC

R. Fernandes, R. Gilmore, L. Ruddick-Collins, K. Rice, K. Gazelakis,G. Moore, A. Vasudevan,J. Zhang, E. Wright, T. Schildkraut, N. Clark, M. Schultz,

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023): 190-192

引用0浏览0引用

Outcomes for people with inflammatory bowel disease receiving dose-escalated adalimumab therapy: Crohn's Colitis Cure data insights program

L. Mcgrory, J. Mcnamara,W. Wilson, T. Goodfellow, J. Pipicella, W. Ng, S. Ghaly, R. Gearry, A. Forbes,Y-K An, K. Lynch, I. Lawrence,

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023): 163-163

引用0浏览0引用

Vedolizumab has longer persistence than infliximab for ulcerative colitis in a real-world cohort study: Preliminary results from the COMPARE-IT study

A. Shanmuga Anandan, R. Fernandes, A. Etchegaray, R. Malloy, P. Selvanathan, R. Gilmore,H. Pham, J. Begun,Y-K An

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023): 177-178

引用0浏览0引用

Australian consensus on ustekinumab in Crohn's disease

J. Begun,Y-K An, R. Bryant, B. Christensen, R. Leong, C. Studd, L. Thin

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023): 136-137

引用0浏览0引用

Cessation of corticosteroids after acute severe ulcerative colitis may be associated with increased colectomy risk: Results of the ANZ-ASUC study in collaboration with the ANZIBDC

R. Fernandes, R. Gilmore, L. Ruddick-Collins, K. Rice,G. Moore, K. Gazelakis, A. Vasudevan,J. Zhang, E. Wright, T. Schildkraut, N. Clark, M. Schultz,

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023): 186-187

引用0浏览0引用

Reducing hospital resource utilization and improving patient satisfaction with an innovative inflammatory bowel disease nurse-led clinical care pathway with rapid-access intestinal ultrasound

R. Fernandes, H. Harris, E. Khoo, R. Gilmore, M. Howlett, N. Walker, P. Hendy, J. Begun,Y-K An

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023): 192-193

引用0浏览0引用

Australian multicenter real-world experience of upadacitinib induction therapy for moderate to severe ulcerative colitis

R. Gilmore, R. Fernandes, I. Hartley, A. Arzivian, R. Leong, B. Andrew, A. Vasudevan, T. Greeve,G. Moore,S. Kim, D. Lightowler,A. Singh,

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023): 185-186

引用0浏览0引用

Comparing long-term outcomes in patients with inflammatory bowel disease between switch and non-switch cohorts: No differences in infliximab persistence or safety outcomes after 54 months

P. Suo, L. Thin,A. Srinivasan,Y-K An, R. Fernandes,S. Ghaly, A. Jeffrey,S. Menon, J. Winston, C. Haifer

Journal of Crohn's and Colitis（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn